Covalon Technologies Ltd. announced that Mr. John Suk has joined Covalon’s Board of Directors. Mr. Suk is an experienced executive within Canada’s pharmaceutical and healthcare industries. After holding senior executive roles at McNeil Labs (Johnson & Johnson), GlaxoSmithKline plc, and Hoffman La Roche, Mr. Suk founded, in 1997, Byk Canada (later known as Nycomed), a subsidiary of German company Byk Gulden.